Spire Wealth Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.6K | Sell |
148
-23
| -13% | -$2.9K | ﹤0.01% | 1536 |
|
|
2025
Q1 | $23.5K | Buy |
171
+45
| +36% | +$6.17K | ﹤0.01% | 1555 |
|
|
2024
Q4 | $19.2K | Sell |
126
-129
| -51% | -$19.7K | ﹤0.01% | 1636 |
|
|
2024
Q3 | $49.4K | Buy |
255
+28
| +12% | +$5.43K | ﹤0.01% | 1135 |
|
|
2024
Q2 | $52.6K | Sell |
227
-283
| -55% | -$65.6K | ﹤0.01% | 1102 |
|
|
2024
Q1 | $110K | Sell |
510
-126
| -20% | -$27.2K | ﹤0.01% | 967 |
|
|
2023
Q4 | $159K | Buy |
636
+55
| +9% | +$13.8K | 0.01% | 829 |
|
|
2023
Q3 | $149K | Sell |
581
-99
| -15% | -$25.5K | 0.01% | 808 |
|
|
2023
Q2 | $194K | Sell |
680
-14
| -2% | -$3.99K | 0.01% | 724 |
|
|
2023
Q1 | $193K | Buy |
694
+316
| +84% | +$87.9K | 0.01% | 733 |
|
|
2022
Q4 | $105K | Buy |
378
+43
| +13% | +$11.9K | 0.01% | 724 |
|
|
2022
Q3 | $89K | Sell |
335
-193
| -37% | -$51.3K | 0.01% | 747 |
|
|
2022
Q2 | $108K | Sell |
528
-497
| -48% | -$102K | ﹤0.01% | 1006 |
|
|
2022
Q1 | $216K | Sell |
1,025
-1,334
| -57% | -$281K | 0.01% | 858 |
|
|
2021
Q4 | $566K | Buy |
2,359
+1,244
| +112% | +$298K | 0.01% | 653 |
|
|
2021
Q3 | $316K | Hold |
1,115
| – | – | 0.01% | 732 |
|
|
2021
Q2 | $386K | Sell |
1,115
-1,425
| -56% | -$493K | 0.01% | 694 |
|
|
2021
Q1 | $707K | Buy |
+2,540
| New | +$707K | 0.02% | 556 |
|